PHARMA NEWS, MULT...
Follow
Find
29.4K views | +97 today

2014 : tipping point for HCPs digital natives

From fr.slideshare.net

2014 - the is the year of the digital native. Pharma spending is still heavily allocated toward analog native customers.
No comment yet.

3 simple principles for integrating Solution Selling into the iPad e-detail

From www.vertic.com

The pharmaceutical industry has experienced an increase in the cost per sales rep visit and a decrease in average time per visit and # visits accepted by the physicians.
eMedToday's curator insight, April 23, 2013 11:29 PM

The pharmaceutical industry has experienced an increase in the cost per sales rep visit and a decrease in average time per visit and # visits accepted by the physicians. A well organized presentation using an ipad by a sales rep can change this trend

Cancer entering the world of DTC marketing ?

From worldofdtcmarketing.com

Millennium Pharmaceuticals, based in Cambridge, has launched a consumer website called "Mymultiplemyeloma.com" and it's a very good effort to reach out to patients of this horrible disease and prov...
No comment yet.

PhRMA Report 2013: Medicines in Development: Biologics

From fr.slideshare.net

America’s biopharmaceutical research companies are developing 907 biologics targeting more than 100 diseases. Biologics are developed through biological proce
No comment yet.

Le marketing digital représente 2,5% du CA des entreprises aux USA

From www.offremedia.com

Le marketing digital représente 2,5% du CA des entreprises aux ...
No comment yet.

Diabète : l'industrie pharmaceutique surfe sur les réseaux sociaux

From descrabesetdeshommes.wordpress.com

Les personnes souffrant de maladies chroniques, comme le diabète, ont investi les réseaux sociaux en masse pour s'informer et se soutenir. Il n'a pas fallu longtemps à l'industrie pharmaceutique po...
No comment yet.

Docs to pharma marketers: you're not getting it

From www.mmm-online.com

An ePharma Summit panel of physicians takes the sheen off new marketing initiatives by telling pharmas they find them useless.
No comment yet.

Moving commercial teams into the future of effectiveness

From pharmalive.com

Moving commercial teams into the future of effectiveness – via @MedAdNews - http://t.co/PD1Zi0z1mi
No comment yet.

La convergence de l’industrie médicale et du digital en une seule image

From www.demainlaveille.fr

La relation entre industriels du monde de la santé, les patients, leurs familles et entourages ainsi que les régulateurs et autres institutions ne cesse...
No comment yet.

US Pharma Marketing Spend Falls for Most Channels - eMarketer

From www.emarketer.com

Pharma firms in the US displayed cautiousness in 2012, with promotional spending dropping 8% year over year. Detailing commanded the largest chunk of advertising spending in 2012, but saw a decline from 2011.
No comment yet.

PhRMA Report 2013: Medicines in Development: Biologics

From fr.slideshare.net

America’s biopharmaceutical research companies are developing 907 biologics targeting more than 100 diseases. Biologics are developed through biological proce
No comment yet.

Deloitte | Physician Perspectives About Health Information Technology | Issue brief | Survey of physicians assesses their curren

From www.deloitte.com

This survey of physicians assesses their current use and overall views of HIT, as well as actions around electronic health records, meaningful use, and ICD (RT @DeloitteHealth: How valuable is #EHR use by physicians in improving quality and...
No comment yet.

Pharma eDetaling: core to its new commercial development | Health Business Consult

From www.healthbusinessconsult.com

Pharma’s new commercial model is not easily created.

 

We see Pharma companies to add all sorts of new programs to their company, like “Closed Loop Marketing”, “Sales Force Effectiveness”, “Key Account Management”, “Key Opinion Leader Management”, “Customer First”, or “Customer Excellence”, “Market Access management” etc.

Surely all kinds of innovations to focus and approach promotion in a new way.
Also, Social Media, Websites and On line Communities are created to “get the word out..”


But for now, we want to focus on edetailing as a core aspect for triggering the road map to create more effect and collaboration with customers (physicians and other caregivers) to support patients’ therapies, such as compliance support. ...

See presentation

 

rob halkes's curator insight, March 15, 2013 5:24 AM

Looking forward to the development of a new commercial approach of pharma, not "just" as supplier of medications, but as full partner in caring for health. Co-creating health with all protagonists!

Integrate sales-force efforts with eDetails to lift market share

From www.closerlook.com

Michael Kirby discusses how eDetailing has proven effective in giving sales reps greater access to physicians and eDetailing and sales reps work "better together."
eMedToday's curator insight, April 30, 2013 2:41 AM

The conclusion:  the more effective the integration of a brand's sales and eDetailing efforts, the greater the positive change in prescribing behavior.

Infographie : L'influence du digital sur le parcours client

From www.e-marketing.fr

La multiplication des dispositifs digitaux n'est pas sans conséquence sur le comportement des consommateurs.

No comment yet.

La révolution numérique en marche dans l’industrie pharmaceutique

From dviews.deloitte-france.fr

Les entreprises du médicament n’ont jusqu’à présent que peu tiré profit du gisement d’innovation et de productivité que représente le numérique. Pourtant, ces technologies constituent un formidable...
No comment yet.

7 Emerging Trends in Pharma Communications | HealthWorks Collective

From healthworkscollective.com

As we charge into 2013, there is a cautious air of optimism that the pharma industry is showing signs of adaptation and innovation in its business models.
No comment yet.

Pharma Trimmed 2012 Promotional Spending by 8%, Research Firm Reports | Beyond The Pill

From beyondthepill.medivo.com

Pharma marketers were a cautious lot in 2012. According to a report from Cegedim Strategic Data, marketers reduced their promotional spending for Rx drugs by 8% in 2012.

This was an even steeper percentage decline than the cutbacks in promotional spending that took place in 2011, according to the report. Yet, pharma companies did spend more than $27 billion in the U.S. market on the promotion of drug products.

“Promotional spending in the pharmaceutical industry continued to decline in 2012, shedding dollars directed at consumers and expenditures supporting HCP detailing and sampling,” Cegedim reported.

 

No comment yet.

Beyond the Pill: More than Just a Slogan | eyeforpharma

From social.eyeforpharma.com

"You need to truly understand what the patient journey is like and what kind of support is needed" http://t.co/O9xYur6Kjl
No comment yet.

Industrie pharmaceutique en France. QUEL AVENIR?

From industrie-pharmaceutique-quel-avenir.blogspot.com

Les 4 grandes mutations subies par l'industrie pharmaceutique[1] : Evolution de la promotion auprès des prescripteurs : nous passons d'un modèle quantitatif (visite médicale intense) à un modèle plus ciblé, pertinent, ...
No comment yet.

Pharma still not spending enough on digital

From worldofdtcmarketing.com

At first the stat looks impressive; pharma is among the leaders in percentage increases in digital spending but when you look at how much they are spending on interactive they are near the bottom of the list. While most CPG marketers have been experimenting with social media and spending more money on digital most pharma companies are still stuck in the dark ages and spend marketing dollars on marketing that is ignored by consumers. I keep hearing the question, “why is pharma ignoring social media ?”. There is more than one reason. First the FDA has decided to act like big government and still does not acknowledge how consumers are using the internet for health. They have not issues and guidelines but even if they did pharma marketers are ill prepared to implement social media because it would take most of them too long to develop a strategy. Then there are the resource issues. Pharma is getting squeezed with key drugs off patent and the government wanting deeper discounts on top drugs.

Pharmaceutical sales representatives an - PubMed Mobile

From www.ncbi.nlm.nih.gov

@Bet_Hall @faejones @davidecarroll do the surgeons get paid for these 'perceptorships' http://t.co/0i1AG8851r
No comment yet.